CSF1R and glioblastoma: In a current clinical study, the combination of radiation and CSF-1R inhibitor is being tested in glioblastoma, and a Phase Ib/II study of combined PLX3397, radiation therapy, and temozolomide in patients with primary glioblastoma (NCT01790503) recently completed recruitment.